JENNIFER WOOD: Open Payments
NPI 1255039244 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,714 in 49 payments from 12 companies in 2025. Trend: 2023 $808 · 2024 $1,820 · 2025 $1,714
Food & beverage: $1,714
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $459 |
| ABBVIE INC. | 11 | $306 |
| Teva Pharmaceuticals USA, Inc. | 3 | $226 |
| Janssen Pharmaceuticals, Inc | 7 | $212 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $151 |
| Otsuka America Pharmaceutical, Inc. | 2 | $122 |
| Braeburn Inc. | 1 | $119 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Alkermes, Inc. | 1 | $23 |
Products named: Auvelity, VRAYLAR, AUSTEDO XR, SPRAVATO, CAPLYTA, REXULTI, BRIXADI, Qelbree.
Industry payments across IN — which companies pay providers there.
